Adaptive Biotechnologies' Chief Operating Officer Sold Over 19,000 Company Shares. Here's What That Means for Investors.
4/5 23:49
Key PointsCOO Julie Rubinstein sold 19,037 shares for a transaction value of ~$271,000 on April 27, 2026, at a weighted average price of around $14.23 per share....